Frontiers in Human Embryonic Stem Cells

人类胚胎干细胞的前沿

• 批准号: 7227085
• 负责人: GERALD SCHATTEN
• 金额: $ 18.36万
• 依托单位: MAGEE-WOMEN'S RES INST AND FOUNDATION
• 依托单位国家: 美国
• 财政年份: 2003
• 资助国家: 美国
• 起止时间: 2003-04-23 至 2009-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7227085
• 关键词: Address; Animals; Area; Arts; Authorship; Award; BG01; BG02; Belief; Cell Line; Cellular biology; Clinical; Cloning; Collaborations; Conflict of Interest; Continuing Education; Country; Daily; Development; ES02; ES04; Educational workshop; Embryo; Embryonic Development; Ensure; Environmental Protection; Faculty; Food; Forensic Medicine; Fostering; Fraud; Freezing; Funding Opportunities; Gametogenesis; Gene Transfer Techniques; Goals; Hand; Human; Industry; Instruction; Karyotype determination procedure; Knowledge; Laboratories; Laboratory Research; Learning; Legal; Legal patent; Life; MI01; Maintenance; Mentors; Methods; Molecular; Molecular Genetics; Oral; Pharmaceutical Preparations; Phenotype; Physicians; Policies; Principal Investigator; Professional counselor; Protocols documentation; Publications; Purpose; Quality Control; Recommendation; Recording of previous events; Regulation; Religion and Spirituality; Research; Research Personnel; Resources; Reverse Transcriptase Polymerase Chain Reaction; Rights; SA01; SA02; Scientist; Senior Scientist; Series; Short-Term Course; Site; Stem Cell Research; Stem cells; Students; Techniques; Teratoma; Training; UC06; Undifferentiated; United States Food and Drug Administration; United States National Academy of Sciences; United States National Institutes of Health; WA01 cell line; WA07 cell line; WA09 Cell Line; Week; Whistleblowing; Work; career; cell growth; cell type; concept; design; experience; frontier; human disease; human embryonic stem cell; immunocytochemistry; interest; lecturer; lectures; member; pluripotency; posters; programs; relating to nervous system; stem; success

DESCRIPTION (provided by applicant): This is the first renewal application of our T15 award to offer a Short-Term Course in hESC research. Frontiers in Human Embryonic Stem Cells (FrHESC) is a dynamic advanced training course that offers a fresh series of daily lecturers on emerging concepts, followed by extended discussion, laboratory research, technologically intense workshops and informal seminars over a three week period (June 11-28, 2006).The Course is directed toward young independent scientists, physicians and established investigators. It will address critical concerns in stem cell biomedicine and is organized around four modules: Module A. hESC Growth, Propagation, and Pluripotency; Module B. Transgenesis, Cloning and Epigenesis in hESCs; Module C. Realizing the Clinical Promise of hESCs and Module D. Continuing Education. The Frontiers in Human Embryonic Stem CellsTraining Course Program is directed by a Board of Scientific Counselors, whose members are renowned leaders in hESC research, proactively consider the national needs for this undertaking and solicit the intellectual and financial resources to realize the promise of Human Embryonic Stem Cell Research. The FrHESC training course itself is organized by two Course Directors, Gerald Schatten and Roger Pedersen, who are experts in molecular cell biology, gametogenesis, preimplantation embryogenesis and stem cell research. The laboratory and lecture faculty selected to participate in the course are internationally acknowledged leaders in their fields. The purpose of this training course is to provide comprehensive and sophisticated training in research strategies and state-of-the-art methods on cellular, molecular and genetic approaches for advancing the Frontiers in Human Embryonic Stem Cell Research. To do so, the course will provide hands-on experience using a panel of some of the following NIH- approved hESC cell lines: BG01, BG02, SA01, SA02, HES2, HESS, HES4, MI01, UC06, WA01, WA07, WA09. These lines, which are currently in use at the Pittsburgh Development Center, were chosen because FrhESC faculty has experience with these lines. Using lines that faculty has extensive experience with and that are already in place on the course site will ensure the success of the hands-on training for the students.

描述（由申请人提供）：这是我们T15奖的首次续签，以提供hESC研究的短期课程。人类胚胎干细胞（FRHESC）的前沿是一个动态的高级培训课程，为新兴概念提供了新的每日讲师，随后进行了长时间的讨论，实验室研究，技术激烈的研讨会和非正式研讨会和非正式的研讨会（2006年6月11日至28日）。该课程针对年轻的独立科学家，生理学家和老师。它将解决干细胞生物医学的关键问题，并在四个模块周围组织：模块A. hESC生长，传播和多能性；模块B. hESC中的转基因，克隆和表观遗传；模块C.意识到HESC和模块的临床承诺。继续教育。人类胚胎干细胞培养课程计划的前沿是由科学顾问委员会指导的，其成员是hESC研究的知名领导者，主动考虑了这项工作的国家需求，并征求知识和财务资源，以实现人类胚胎干细胞研究的承诺。 FRHESC培训课程本身由两位课程主管Gerald Schatten和Roger Pedersen组织，他们是分子细胞生物学，配子发生，植入前胚胎发生和干细胞研究专家。选择参加该课程的实验室和演讲学院是国际公认的领导者。本培训课程的目的是在研究策略和最先进的方法中提供有关细胞，分子和遗传方法的最新方法，以推进人类胚胎干细胞研究中的前沿。为此，该课程将使用以下一些NIH批准的HESC单元线的面板提供动手体验：BG01，BG02，SA01，SA01，SA02，HES2，HES2，HESS，HESS，HES4，MI01，UC06，UC06，WA01，WA01，WA07，WA07，WA09。这些线路目前在匹兹堡开发中心使用的线路之所以选择，是因为Frhesc教师在这些线路方面具有经验。使用教师具有丰富经验的线条，并且在课程站点上已经有了足够的经验，将确保为学生进行动手实践培训的成功。